← Back to Search

Self-Directed Weight Loss with year-long weight tracking for Bladder Cancer (ASPIRE Trial)

N/A
Waitlist Available
Led By Jessica Yeh, Ph.D.
Research Sponsored by Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up end of enrollment, up to 2 years
Awards & highlights

ASPIRE Trial Summary

This trial is testing a weight loss program for overweight and obese cancer survivors in Maryland.

Eligible Conditions
  • Bladder Cancer
  • Breast Cancer
  • Prostate Cancer
  • Skin Cancer
  • Gallbladder Cancer
  • Endometrial Cancer
  • Colorectal Cancer
  • Kidney Cancer

ASPIRE Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~end of enrollment, up to 2 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and end of enrollment, up to 2 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Weight change at 6 months in Coach-Directed Program
Secondary outcome measures
Weight change at 6 months in Self-Directed and App-Directed Weight Loss Programs
Other outcome measures
Adoption of weight loss program activities as assessed by app use frequency
Implementation of weight loss program as assessed by a participant survey
Program participation as assessed by participant enrollment
+1 more

ASPIRE Trial Design

3Treatment groups
Experimental Treatment
Group I: Self-Directed Weight Loss with year-long weight trackingExperimental Treatment1 Intervention
Written Weight Loss Material.
Group II: Coach-Directed Weight Loss with year-long weight trackingExperimental Treatment2 Interventions
Behavioral Lifestyle Weight Loss Intervention with Smart phone Weight Loss App.
Group III: App-Directed Weight Loss with year-long weight trackingExperimental Treatment1 Intervention
Smart phone Weight Loss App.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Weight Loss App
2020
N/A
~340
Behavioral Lifestyle Weight Loss Intervention (Coaching)
2020
N/A
~340
Written Weight Loss Material
2020
N/A
~340

Find a Location

Who is running the clinical trial?

Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsLead Sponsor
556 Previous Clinical Trials
32,526 Total Patients Enrolled
Maryland Cigarette Restitution FundOTHER_GOV
5 Previous Clinical Trials
257 Total Patients Enrolled
Jessica Yeh, Ph.D.Principal InvestigatorJohns Hopkins University

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is the research team currently recruiting for participants?

"The clinical trial data available on clinicaltrials.gov shows that this particular study is not accepting new candidates at present. It was initiated on September 22, 2020 and last modified on March 2nd 2022. However, there are 3195 other trials actively searching for participants across the world right now."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
Behavioral Weight Loss Program for Cancer Survivors in Maryland
2020. "Behavioral Weight Loss Program for Cancer Survivors in Maryland". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04534309.
~76 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top